AJTMH ASTMH Job Mart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 62(3), 2000, pp. 402-408
Copyright © 2000 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kshirsagar, N.
Right arrow Articles by Gathmann, I
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kshirsagar, N.
Right arrow Articles by Gathmann, I
Related Collections
Right arrow Malaria
Right arrow Plasmodium
American Journal of Tropical Medicine and Hygiene, Vol 62, Issue 3, 402-408
Copyright © 2000 by American Society of Tropical Medicine and Hygiene

Research Articles


A randomized, double-blind, parallel-group, comparative safety, and efficacy trial of oral co-artemether versus oral chloroquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in adults in India

NA Kshirsagar, NJ Gogtay, NS Moorthy, MR Garg, SS Dalvi, AR Chogle, JS Sorabjee, SN Marathe, GH Tilve, AD Bhatt, SP Sane, R Mull, and I Gathmann

In India, treatment of acute, uncomplicated Plasmodium falciparum malaria is becoming increasingly difficult due to resistance to chloroquine, thus there is a need for new antimalarial drugs. CGP 56697 (co-artemether), a new drug, is a combination of artemether and lumefantrine in a single oral formulation (one tablet = 20 mg of artemether plus 120 mg of lumefantrine). In a double-blind study, 179 patients with acute uncomplicated P. falciparum malaria were randomly assigned to receive either CGP (n = 89) given as a short course of 4 x 4 tablets over a 48-hr period or chloroquine (n = 90) given as four tablets (one tablet = 150 mg of chloroquine base) initially, followed by two tablets each at 6-8, 24, and 48 hr. Due to a death in the chloroquine group and a decrease in the chloroquine cure rate to < 50% (based on the blinded overall cure rate at that time), recruitment was terminated prematurely. CGP 56697 showed a superior 28-day cure rate (95.4% versus 19.7%; P < 0.001), time to parasite clearance (median = 36 versus 60 hr; P < 0.001), and resolution of fever (median = 18 versus 27 hr; P = 0.0456). This drug provides a safe, effective, and rapid therapy for the treatment of acute uncomplicated P. falciparum malaria.


This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
R. J. Maude, K. Plewes, M. A. Faiz, J. Hanson, P. Charunwatthana, S. J. Lee, J. Tarning, E. B. Yunus, M. G. Hoque, M. U. Hasan, et al.
Does Artesunate Prolong the Electrocardiograph QT Interval in Patients with Severe Malaria?
Am J Trop Med Hyg, January 1, 2009; 80(1): 126 - 132.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
M. MAKANGA, Z. PREMJI, C. FALADE, J. KARBWANG, E. A. MUELLER, K. ANDRIANO, P. HUNT, and P. I. DE PALACIOS
EFFICACY AND SAFETY OF THE SIX-DOSE REGIMEN OF ARTEMETHER-LUMEFANTRINE IN PEDIATRICS WITH UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA: A POOLED ANALYSIS OF INDIVIDUAL PATIENT DATA
Am J Trop Med Hyg, June 1, 2006; 74(6): 991 - 998.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Society of Tropical Medicine and Hygiene.